Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2026-01-02 @ 5:37 AM
Study NCT ID:
NCT06754267
Status:
RECRUITING
Last Update Posted:
2024-12-31
First Post:
2024-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL
Sponsor:
First Affiliated Hospital of Zhejiang University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IIT20240094C
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None